Rossmax International Ltd
Rossmax International Ltd. develops and supplies healthcare products and solutions. The company offers body fat monitors and scales that are used to measure body fat, body mass index, lean mass, muscle mass, and water ratio along with body weight; blood pressure monitors; sphygmomanometer, a device that measures blood pressure; stethoscope, an acoustic medical device for auscultation, or listenin… Read more
Rossmax International Ltd (4121) - Net Assets
Latest net assets as of June 2025: NT$2.03 Billion TWD
Based on the latest financial reports, Rossmax International Ltd (4121) has net assets worth NT$2.03 Billion TWD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$4.14 Billion) and total liabilities (NT$2.12 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$2.03 Billion |
| % of Total Assets | 48.91% |
| Annual Growth Rate | 6.41% |
| 5-Year Change | 25.84% |
| 10-Year Change | N/A |
| Growth Volatility | 9.35 |
Rossmax International Ltd - Net Assets Trend (2017–2024)
This chart illustrates how Rossmax International Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Rossmax International Ltd (2017–2024)
The table below shows the annual net assets of Rossmax International Ltd from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$2.09 Billion | +12.84% |
| 2023-12-31 | NT$1.85 Billion | -4.80% |
| 2022-12-31 | NT$1.94 Billion | +9.27% |
| 2021-12-31 | NT$1.78 Billion | +7.20% |
| 2020-12-31 | NT$1.66 Billion | +24.67% |
| 2019-12-31 | NT$1.33 Billion | -0.72% |
| 2018-12-31 | NT$1.34 Billion | -0.84% |
| 2017-12-31 | NT$1.35 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Rossmax International Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 25.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$345.01 Million | 23.26% |
| Other Components | NT$1.14 Billion | 76.74% |
| Total Equity | NT$1.48 Billion | 100.00% |
Rossmax International Ltd Competitors by Market Cap
The table below lists competitors of Rossmax International Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ovostar Union N.V.
WAR:OVO
|
$34.41 Million |
|
Fosterville South Exploration Ltd
OTCQX:FSXLF
|
$34.41 Million |
|
SDI Ltd
AU:SDI
|
$34.42 Million |
|
ANGLE plc
OTCQX:ANPCF
|
$34.42 Million |
|
Mikro MSC Bhd
KLSE:0112
|
$34.39 Million |
|
Valartis Group AG
SW:VLRT
|
$34.38 Million |
|
Deleum Bhd
KLSE:5132
|
$34.37 Million |
|
Inv Tricahue
SN:TRICAHUE
|
$34.37 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Rossmax International Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,443,789,000 to 1,482,968,000, a change of 39,179,000 (2.7%).
- Net loss of 29,348,000 reduced equity.
- Dividend payments of 48,785,000 reduced retained earnings.
- New share issuances of 8,440,000 increased equity.
- Other factors increased equity by 108,872,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$-29.35 Million | -1.98% |
| Dividends Paid | NT$48.78 Million | -3.29% |
| Share Issuances | NT$8.44 Million | +0.57% |
| Other Changes | NT$108.87 Million | +7.34% |
| Total Change | NT$- | 2.71% |
Book Value vs Market Value Analysis
This analysis compares Rossmax International Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.04x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.17x to 1.04x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | NT$15.39 | NT$18.00 | x |
| 2018-12-31 | NT$15.19 | NT$18.00 | x |
| 2019-12-31 | NT$15.16 | NT$18.00 | x |
| 2020-12-31 | NT$18.13 | NT$18.00 | x |
| 2021-12-31 | NT$17.03 | NT$18.00 | x |
| 2022-12-31 | NT$18.21 | NT$18.00 | x |
| 2023-12-31 | NT$17.00 | NT$18.00 | x |
| 2024-12-31 | NT$17.36 | NT$18.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Rossmax International Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.98%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.76%
- • Asset Turnover: 0.91x
- • Equity Multiplier: 2.85x
- Recent ROE (-1.98%) is below the historical average (4.07%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 2.43% | 0.88% | 1.31x | 2.12x | NT$-86.01 Million |
| 2018 | 1.48% | 0.54% | 1.35x | 2.05x | NT$-95.56 Million |
| 2019 | 2.30% | 0.83% | 1.01x | 2.74x | NT$-86.20 Million |
| 2020 | 10.10% | 3.68% | 1.10x | 2.50x | NT$1.33 Million |
| 2021 | 7.70% | 2.82% | 1.05x | 2.60x | NT$-33.19 Million |
| 2022 | 10.97% | 3.92% | 1.09x | 2.57x | NT$15.00 Million |
| 2023 | -0.46% | -0.17% | 0.93x | 2.83x | NT$-151.04 Million |
| 2024 | -1.98% | -0.76% | 0.91x | 2.85x | NT$-177.64 Million |
Industry Comparison
This section compares Rossmax International Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,135,798,889
- Average return on equity (ROE) among peers: 10.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Rossmax International Ltd (4121) | NT$2.03 Billion | 2.43% | 1.04x | $34.41 Million |
| Health & Life Co., Ltd. (1781) | $393.05 Million | 6.17% | 1.08x | $12.92 Million |
| Hi-Clearance (1788) | $3.00 Billion | 11.98% | 0.65x | $104.25 Million |
| Radiant Innovation (3373) | $865.89 Million | -3.30% | 0.08x | $18.76 Million |
| Wellell Inc (4106) | $458.47 Million | 22.17% | 0.32x | $37.12 Million |
| United Orthopedic (4129) | $2.22 Billion | 5.87% | 0.94x | $279.97 Million |
| Dynamic Medical Technologies (4138) | $1.70 Billion | 12.34% | 0.81x | $39.16 Million |
| Ok Biotech Co Ltd (4155) | $452.10 Million | 21.38% | 0.72x | $44.61 Million |
| Bioptik Technology (4161) | $824.15 Million | 10.40% | 0.82x | $30.48 Million |
| EPS Bio Technology Corp. (4183) | $304.55 Million | 5.68% | 0.78x | $4.27 Million |